Drugs / tumor-pulsed dendritic cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00006434 | — | non-Hodgkin lymphoma | National Center for Research Resources (NCRR) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | tumor-pulsed dendritic cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00006434 ↗ |
| Modality | Vaccine | “an investigational vaccine that consists of tumor-pulsed dendritic cells” NCT00006434 ↗ |